专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06824625B2 Magnetostriction control alloy sheet, a part of a braun tube, and a manufacturing method for a magnetostriction control alloy sheet 失效
标题翻译：磁致伸缩控制合金板，Braun管的一部分，以及磁致伸缩控制合金板的制造方法
公开(公告)号：US06824625B2
公开(公告)日：2004-11-30
申请号：US09909396
申请日：2001-07-19
申请人： Norio Fukuda , Shinya Nakamura , Hiroyuki Yamada , Akira Makita , Tsutomu Hatano , Nobuaki Kanayama , Takahito Aoki
发明人： Norio Fukuda , Shinya Nakamura , Hiroyuki Yamada , Akira Makita , Tsutomu Hatano , Nobuaki Kanayama , Takahito Aoki
IPC分类号： H01F116
CPC分类号： C21D8/0205 , C21D8/0236 , C21D8/0273 , C22C38/004 , C22C38/04 , C22C38/52 , H01J29/07 , H01J2229/0733
摘要： The invention relates to a magnetostriction control alloy sheet advantageously used as a high resolution shadow mask having a low coefficient of thermal expansion, superior magnetic properties and a high Young's modulus after a blackening process, a manufacturing process for the same, and a part for a color Braun tube such as a shadow mask. The magnetostriction control alloy sheet comprises C at 0.01 wt. % or less, Ni at 30 to 36 wt. %, Co at 1 to 5.0 wt. %, and Cr at 0.1 to 2 wt. %, the remainder Fe and unavoidable impurities, and having a magnetostriction &lgr; after the softening and annealing of (−15×10−6) to (25×10−6).
摘要翻译：本发明涉及一种有利地用作高分辨率荫罩的磁致伸缩控制合金薄片，其具有低的热膨胀系数，优异的磁性能和在黑化处理之后的高杨氏模量，其制造方法和用于彩色Braun管如荫罩。磁致伸缩控制合金薄板包含0.01wt。％以下，Ni为30〜36重量％。％，Co为1〜5.0wt。％，Cr为0.1〜2wt。％，剩余的Fe和不可避免的杂质，并且在（-15x10 -6）至（25×10 -6）的软化和退火之后具有磁致伸缩λ。

2. 发明授权

US5236522A Fe-Ni-Co alloy for a shadow mask 失效
标题翻译： FE-NI-CO合金用于阴影面膜
公开(公告)号：US5236522A
公开(公告)日：1993-08-17
申请号：US951099
申请日：1992-09-25
申请人： Norio Fukuda , Naofumi Nakamura , Atushi Hattori , Hideya Itoh , Akira Makita , Tsutomu Hatano
发明人： Norio Fukuda , Naofumi Nakamura , Atushi Hattori , Hideya Itoh , Akira Makita , Tsutomu Hatano
IPC分类号： C22C38/00 , C22C38/10 , H01J29/07
CPC分类号： C22C38/10 , H01J29/07 , H01J2229/0733
摘要： In an Fe-base alloy, Ni is contained by 28 to 34% by weight and Co by 2 to 7% by weight with an average grain size of 30 .mu.m or less. 60 to 95% of crystal grains are oriented in a range of .+-.5 to 45 degrees deviated from the ideal orientation of {100} [001]. Resultant low thermal expansion of the alloy assures high doming characteristics of a shadow mask made thereof.

3. 发明授权

US07718805B2 Process for preparing rebamipide 有权
标题翻译：制备瑞巴派特的方法
公开(公告)号：US07718805B2
公开(公告)日：2010-05-18
申请号：US10587509
申请日：2005-11-30
申请人： Shinji Nishitani , Norio Fukuda
发明人： Shinji Nishitani , Norio Fukuda
IPC分类号： C07D215/38
CPC分类号： C07D215/227
摘要： The invention provides an improved process for preparing rebamipide that is useful as a medicament, which makes it possible to prepare rebamipide with high purity and high yield. The invention is an improved process for preparing rebamipide of the formula (1), comprising subjecting a carbostyril amino acid compound of the formula (5) or a salt thereof containing a compound of the formula (11) as an impurity to a reduction treatment in the presence of hydrogen and a catalyst in a basic aqueous solution, thereby selectively reducing the impurity compound (11) to transform into the carbostyril amino acid compound (5); and then acylating the compound (5) in a basic aqueous solution to give rebamipide (1).
摘要翻译：本发明提供了一种用于制备可用作药物的瑞巴派特的改进方法，其使得可以以高纯度和高产率制备瑞巴派特。本发明是制备式（1）的瑞巴派特的改进方法，其包括使式（5）的喹诺酮类氨基酸化合物或其含有式（11）化合物的盐作为杂质进行还原处理在碱性水溶液中存在氢和催化剂，从而选择性地还原杂质化合物（11）以转化成喹诺酮类氨基酸化合物（5）; 然后在碱性水溶液中酰化化合物（5），得到瑞巴派特（1）。

4. 发明申请

US20120289836A1 AUTOMATIC REAL-TIME DISPLAY SYSTEM FOR THE ORIENTATION AND LOCATION OF AN ULTRASOUND TOMOGRAM IN A THREE-DIMENSIONAL ORGAN MODEL 审中-公开
标题翻译：自动实时显示系统，用于三维组织模型中超声波TOMOGRAM的定位和定位
公开(公告)号：US20120289836A1
公开(公告)日：2012-11-15
申请号：US13467913
申请日：2012-05-09
申请人： Osamu Ukimura , Masahiko Nakamoto , Yoshinobu Sato , Norio Fukuda
发明人： Osamu Ukimura , Masahiko Nakamoto , Yoshinobu Sato , Norio Fukuda
IPC分类号： A61B8/12
CPC分类号： A61B8/085 , A61B8/12 , A61B8/14 , A61B8/587
摘要： An automatic real-time display system of the orientation and location of an ultrasound tomogram in a three-dimensional organ model based on the tracking of free-hand manipulation of an ultrasound probe having an AHRS sensor to acquire an entire three-dimensional volume data of an organ and real-time display to visualize the orientation and location of the ultrasound tomogram in three dimensions.
摘要翻译：一种基于对具有AHRS传感器的超声探头的自由手操作的追踪获取三维体积数据的三维器官模型中的超声断层图的取向和位置的自动实时显示系统一个器官和实时显示，可以显示超声断层图在三维方向和位置。

5. 发明授权

US07718806B2 Process for production of carbostyril compound 有权
标题翻译：喹诺酮类化合物生产工艺
公开(公告)号：US07718806B2
公开(公告)日：2010-05-18
申请号：US11596004
申请日：2006-04-07
申请人： Kengo Kawasaki , Takayuki Ikeda , Takeshi Sekine , Norio Fukuda
发明人： Kengo Kawasaki , Takayuki Ikeda , Takeshi Sekine , Norio Fukuda
IPC分类号： C07D215/38
CPC分类号： C07D215/22
摘要： The invention provides an improved process for preparing a carbostyril compound (1) or a salt thereof that is useful as a medicament, which makes it possible to prepare it more safely and efficiently.In more detail, the invention provides an improved process for preparing the carbostyril compound (1) by heating the compound (4) with a high boiling solvent in hydrochloric acid under reflux to give the compound (5) safely; and then acylating the compound (5).
摘要翻译：本发明提供了一种制备喹诺酮化合物（1）或其盐的改进方法，其可用作药物，这使得可以更安全和有效地制备它。更详细地说，本发明提供了一种改进的制备喹诺酮化合物（1）的方法，该方法是用高沸点溶剂在盐酸中回流加热化合物（4），以安全地得到化合物（5）; 然后酰化化合物（5）。

6. 发明申请

US20070299262A1 Process for Production of Carbostyril Compound 有权
标题翻译：碳青霉烯化合物生产工艺
公开(公告)号：US20070299262A1
公开(公告)日：2007-12-27
申请号：US11596004
申请日：2006-04-07
申请人： Kengo Kawasaki , Takayuki Ikeda , Takeshi Sekine , Norio Fukuda
发明人： Kengo Kawasaki , Takayuki Ikeda , Takeshi Sekine , Norio Fukuda
IPC分类号： C07D215/22
CPC分类号： C07D215/22
摘要： The invention provides an improved process for preparing a carbostyril compound (1) or a salt thereof that is useful as a medicament, which makes it possible to prepare it more safely and efficiently. In more detail, the invention provides an improved process for preparing the carbostyril compound (1) by heating the compound (4) with a high boiling solvent in hydrochloric acid under reflux to give the compound (5) safely; and then acylating the compound (5).
摘要翻译：本发明提供了一种制备喹诺酮化合物（1）或其盐的改进方法，其可用作药物，这使得可以更安全和有效地制备它。更详细地说，本发明提供了一种改进的制备喹诺酮化合物（1）的方法，该方法是用高沸点溶剂在盐酸中回流加热化合物（4），以安全地得到化合物（5）; 然后酰化化合物（5）。

7. 发明授权

US5925658A Optically active thiazolidinone derivative 失效
标题翻译：光学活性噻唑烷酮衍生物
公开(公告)号：US5925658A
公开(公告)日：1999-07-20
申请号：US923745
申请日：1997-09-02
申请人： Sadao Ishihara , Fujio Saito , Yasuo Ohhata , Shigeki Miyake , Ryosuke Yorikane , Norio Fukuda
发明人： Sadao Ishihara , Fujio Saito , Yasuo Ohhata , Shigeki Miyake , Ryosuke Yorikane , Norio Fukuda
IPC分类号： C07D277/14 , A61K31/425
CPC分类号： C07D277/14
摘要： An optically active thiazolidinone derivative having the general formula: ##STR1## wherein: R.sup.1 represents a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group, a phenyl group, a substituted phenyl group (said substituent represents C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen), a phenyl-C.sub.1 -C.sub.2 alkyl group or a substituted phenyl-C.sub.3 -C.sub.2 alkyl group (the substituent of said phenyl represents C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen); R.sup.2 represents a C.sub.1 -C.sub.6 alkyl group; and n represents 1 or 2!.EffectThe optically active thiazolidinone derivative of the present invention has excellent anti-angina pectoris action and is useful as a preventive agent or a therapeutic agent for angina pectoris.
摘要翻译：具有以下通式的光学活性噻唑烷酮衍生物：其中：R1表示氢原子，C1-C4烷基，苯基，取代苯基（所述取代基表示C1-C4烷基，C1-C4烷氧基或卤素），苯基-C 1 -C 2烷基或取代的苯基-C 3 -C 2烷基（所述苯基的取代基代表C1-C4烷基，C1-C4烷氧基或卤素）; R2表示C1-C6烷基; n表示1或2]。效果本发明的光学活性噻唑烷酮衍生物具有优异的抗心绞痛作用，可用作心绞痛的预防剂或治疗剂。

8. 发明申请

US20070249835A1 Process for Preparing Rebamipide 有权
标题翻译：制备瑞巴派特的方法
公开(公告)号：US20070249835A1
公开(公告)日：2007-10-25
申请号：US10587509
申请日：2005-11-30
申请人： Shinji Nishitani , Norio Fukuda
发明人： Shinji Nishitani , Norio Fukuda
IPC分类号： C07D215/02
CPC分类号： C07D215/227
摘要： The invention provides an improved process for preparing rebamipide that is useful as a medicament, which makes it possible to prepare rebamipide with high purity and high yield. The invention is an improved process for preparing rebamipide of the formula (1), comprising subjecting a carbostyril amino acid compound of the formula (5) or a salt thereof containing a compound of the formula (11) as an impurity to a reduction treatment in the presence of hydrogen and a catalyst in a basic aqueous solution, thereby selectively reducing the impurity compound (11) to transform into the carbostyril amino acid compound (5); and then acylating the compound (5) in a basic aqueous solution to give rebamipide (1).
摘要翻译：本发明提供了一种用于制备可用作药物的瑞巴派特的改进方法，其使得可以以高纯度和高产率制备瑞巴派特。本发明是制备式（1）的瑞巴派特的改进方法，其包括使式（5）的喹诺酮类氨基酸化合物或其含有式（11）化合物的盐作为杂质进行还原处理在碱性水溶液中存在氢和催化剂，从而选择性地还原杂质化合物（11）以转化成喹诺酮类氨基酸化合物（5）; 然后在碱性水溶液中酰化化合物（5），得到瑞巴派特（1）。

9. 发明授权

US6143763A Carbostyril derivatives 失效
标题翻译：卡波他汀衍生物
公开(公告)号：US6143763A
公开(公告)日：2000-11-07
申请号：US849664
申请日：1997-05-29
申请人： Yasuo Koga , Yoshito Kihara , Minoru Okada , Takao Nishi , Yoshihiro Inoue , Yukio Kimura , Hiroyoshi Hidaka , Norio Fukuda
发明人： Yasuo Koga , Yoshito Kihara , Minoru Okada , Takao Nishi , Yoshihiro Inoue , Yukio Kimura , Hiroyoshi Hidaka , Norio Fukuda
IPC分类号： C07D215/22 , C07D215/227 , A61K31/4704
CPC分类号： C07D215/227
摘要： A carbostyril derivative of the formula (1): ##STR1## wherein A is lower alkylene, R is H, halogen or lower alkoxy, R.sup.1 and R.sup.2 are each lower alkyl being optionally substituted by OH, lower alkoxy, phenyl-lower alkoxy or lower alkanoyloxy; cycloalkyl being optionally substituted by OH, hydroxy-lower alkoxy or lower alkanoyloxy; or amino being optionally substituted by lower alkyl or cycloalkyl, R.sup.3 is H, lower alkyl, lower alkenyl or hydroxy-lower alkyl, and the bond between 3- and 4-positions of the carbostyril nucleus is single or double, provided that when R and R.sup.3 are H, R.sup.1 and R.sup.2 should not be either unsubstituted lower alkyl or unsubstituted cycloalkyl, or a salt thereof, which shows antithrombotic activities, intima thickening inhibitory activity, the platelet mass dissociating activity and increasing activity of the blood flow in the brain and the peripheral vessel, and hence, is useful as medicines in the prophylaxis or treatment of various ischemic diseases.
摘要翻译： PCT No.PCT / JP96 / 02892 Sec。 371日期：1998年5月29日 102（e）日期1998年5月29日PCT提交1996年10月4日PCT公布。公开号WO97 / 12869 日期：1997年04月10日式（1）的喹诺酮衍生物：其中A为低级亚烷基，R为H，卤素或低级烷氧基，R1和R2各自为低级烷基，任选被OH，低级烷氧基，苯基 - 低级烷氧基或低级烷酰氧基; 任选被OH，羟基 - 低级烷氧基或低级烷酰氧基取代的环烷基; 或氨基任选被低级烷基或环烷基取代，R 3是H，低级烷基，低级烯基或羟基 - 低级烷基，并且喹诺酮环的3-和4-位之间的键是单或双，条件是当R和 R3是H，R1和R2不应该是未取代的低级烷基或未取代的环烷基或其盐，其显示抗血栓形成活性，内膜增厚抑制活性，血小板质量分解活性和增加脑中血流的活性，外周血管，因此可用作预防或治疗各种缺血性疾病的药物。

10. 发明授权

US5843973A Thiazolidinone compounds and composition for angina pectoris comprising the compounds as an active ingredient 失效
标题翻译：噻唑烷酮化合物和心绞痛的组合物，其包含该化合物作为活性成分
公开(公告)号：US5843973A
公开(公告)日：1998-12-01
申请号：US872770
申请日：1997-06-10
申请人： Sadao Ishihara , Fujio Saito , Yasuo Ohhata , Shigeki Miyake , Ryosuke Yorikane , Norio Fukuda
发明人： Sadao Ishihara , Fujio Saito , Yasuo Ohhata , Shigeki Miyake , Ryosuke Yorikane , Norio Fukuda
IPC分类号： A61K31/426 , A61K31/427 , A61P9/10 , C07D263/20 , C07D277/14 , C07D277/30 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/12 , A61K31/42 , A61K31/425 , C07D263/24
CPC分类号： C07D263/20 , C07D277/14 , C07D277/30 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/12
摘要： A thiazolidinone compound represented by general formula (I) or a pharmacoligically acceptable salt thereof, ##STR1## wherein W represents sulfur or oxygen and X represents --N(R.sup.1)--, or alternatively X represents sulfur or oxygen and W represents --N(R.sup.1)--, and R.sup.1 represents hydrogen, alkyl or substituted alkyl; R.sup.2 and R.sup.3 are the same or different from each other, and each represents hydrogen, alkyl, substituted alkyl, aryl, or 5- or 6-membered heteroaryl; R.sup.4 represents hydrogen, alkyl or substituted C.sub.1 -C.sub.4 alkyl; R.sup.5 represents substituted cycloalkyl which may contain nitrogen, provided the substituents include --B--ONO.sub.2 (wherein B represents a single bond or alkylene) as the indispensable member and alkyl groups as optional members; and A represents a single bond or alkylene, has an excellent anti-anginal effect and thus is useful as an angina pectoris remedy or preventive.
摘要翻译：由通式（I）表示的噻唑烷酮化合物或其药物学可接受的盐，其中W表示硫或氧，X表示-N（R1） - 或X表示硫或氧，W表示 - N（R1） - ，R1表示氢，烷基或取代的烷基; R2和R3彼此相同或不同，并且各自表示氢，烷基，取代的烷基，芳基或5-或6-元杂芳基; R 4表示氢，烷基或取代的C 1 -C 4烷基; 如果取代基包括-B-ONO2（其中B表示单键或亚烷基）作为不可缺少的成员，并且烷基作为任选的成员，则R5表示可以含有氮的取代的环烷基; 并且A表示单键或亚烷基，具有优异的抗心绞痛作用，因此可用作心绞痛治疗或预防。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式